Marcelo Bigal

CIK 1996637 · View on SEC EDGAR ↗

Insider

First SEC filing: June 12, 2026 · Latest: June 12, 2026

On this page

Insider at

Insider transactions

0 buys (P) 0 sells (S) Net: $0 + 7 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

7 other filings hidden
Date Ticker Code Shares Price Value Owned after Δ own A/D vs now
Aug. 7, 2025 PCRX S 4,912 $23.67 $116,267 11,393 Direct -30.13% Disposed 1.8% (price as of 2026-08-20)
Aug. 16, 2024 PCRX P 1,512 $13.25 $20,034 10,142 Direct +17.52% Acquired 81.8% (price as of 2026-08-20)
Aug. 12, 2024 PCRX P 3,400 $12.01 $40,834 8,630 Direct +65.01% Acquired 100.5% (price as of 2026-08-20)
Aug. 12, 2024 PCRX P 3,400 $12.01 $40,834 8,630 Direct +65.01% Acquired 100.5% (price as of 2026-08-20)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date Ticker Security Underlying Exercise price Expiration Shares A/D
June 10, 2026 PCRX Stock Option (Right to Buy) Common Stock (10,891) $23.42 June 10, 2036 10,891 Acquired
June 11, 2025 PCRX Stock Option (Right to Buy) Common Stock (11,279) $24.34 June 11, 2035 11,279 Acquired
June 12, 2024 PCRX Stock Option (Right to Buy) Common Stock (12,179) $28.68 June 12, 2034 12,179 Acquired
Oct. 6, 2023 PCRX Stock Option (Right to Buy) Common Stock (30,967) $29.80 Oct. 6, 2033 30,967 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).